Iron and ferroptosis: A still ill-defined liaison

IUBMB Life

Volumn 69, Issue 6, 2017, Pages 423-434

  Doll, Sebastian ^a   Conrad, Marcus ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

electrophile signaling; ferritinophagy; glutathione peroxidase 4; Gpx4; labile iron pool; lipid peroxidation; regulated necrosis

Indexed keywords

ADRENIC ACID; ARACHIDONIC ACID; IRON DERIVATIVE; OXYGEN RADICAL; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; ANTIOXIDANT; CYCLOHEXYLAMINE DERIVATIVE; FERROSTATIN-1; GLUTATHIONE PEROXIDASE; IRON; IRON CHELATING AGENT; LIPROXSTATIN-1; PHENYLENEDIAMINE DERIVATIVE; PHOSPHOLIPID-HYDROPEROXIDE GLUTATHIONE PEROXIDASE; QUINOXALINE DERIVATIVE; SPIRO COMPOUND;

APOPTOSIS; CATALYSIS; CELL FUNCTION; CELL STRUCTURE; ENZYME ACTIVITY; FERROPTOSIS; HUMAN; IN VIVO STUDY; IRON METABOLISM; KNOCKOUT MOUSE; LIPID PEROXIDATION; MODULATION; MOLECULAR PATHOLOGY; NONHUMAN; OXYGENATION; REGULATORY MECHANISM; REVIEW; TRANSGENIC MOUSE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL DEATH; DRUG EFFECTS; GENETICS; IRON METABOLISM DISORDER; KIDNEY FAILURE; METABOLISM; NECROSIS; NEUROAXONAL DYSTROPHY; PATHOLOGY; REPERFUSION INJURY;

ANIMALS; ANTIOXIDANTS; CELL DEATH; CYCLOHEXYLAMINES; GLUTATHIONE PEROXIDASE; HUMANS; IRON; IRON CHELATING AGENTS; IRON METABOLISM DISORDERS; LIPID PEROXIDATION; NECROSIS; NEUROAXONAL DYSTROPHIES; PHENYLENEDIAMINES; QUINOXALINES; RENAL INSUFFICIENCY; REPERFUSION INJURY; SPIRO COMPOUNDS;

EID: 85015005588     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1616     Document Type: Review

References (119)

1. Vogt, C. (1842) Untersuchungen über die Entwicklungsgeschichte der Geburtshelferkroete (Alytes obstetricans). Solothurn, Verlag von Jent & Gassmann.
2. Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239–257.
3. Vanden Berghe, T., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., and Vandenabeele, P. (2014) Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Biol. 15, 135–147.
4. Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., et al. (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060–1072.
5. Yang, W. S., Sriramaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., et al. (2014) Regulation of Ferroptotic Cancer Cell Death by GPX4. Cell 156, 317–331.
6. Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., et al. (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180–1191.
7. Frey, P. A., and Reed, G. H. (2012) The ubiquity of iron. ACS Chem. Biol. 7, 1477–1481.
8. Conrad, M., Angeli, J. P., Vandenabeele, P., and Stockwell, B. R. (2016) Regulated necrosis: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 15, 348–366.
9. Bannai, S. (1986) Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J. Biol. Chem. 261, 2256–2263.
10. Sato, H., Tamba, M., Ishii, T., and Bannai, S. (1999) Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274, 11455–11458.
11. Sasaki, H., Sato, H., Kuriyama-Matsumura, K., Sato, K., Maebara, K., et al. (2002) Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J. Biol. Chem. 277, 44765–44771.
12. Itoh, K., Tong, K. I., and Yamamoto, M. (2004) Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic. Biol. Med. 36, 1208–1213.
13. Bannai, S. (1984) Induction of cystine and glutamate transport activity in human fibroblasts by diethyl maleate and other electrophilic agents. J. Biol. Chem. 259, 2435–2440.
14. Bannai, S., Sato, H., Ishii, T., and Sugita, Y. (1989) Induction of cystine transport activity in human fibroblasts by oxygen. J. Biol. Chem. 264, 18480–18484.
15. Bannai, S., Sato, H., Ishii, T., and Taketani, S. (1991) Enhancement of glutathione levels in mouse peritoneal macrophages by sodium arsenite, cadmium chloride and glucose/glucose oxidase. Biochim. Biophys. Acta 1092, 175–179.
16. Bannai, S., and Tateishi, N. (1986) Role of membrane transport in metabolism and function of glutathione in mammals. J. Membr. Biol. 89, 1–8.
17. Conrad, M., and Sato, H. (2012) The oxidative stress-inducible cystine/glutamate antiporter, system x (c) (-): cystine supplier and beyond. Amino Acids 42, 231–246.
18. Chairoungdua, A., Segawa, H., Kim, J. Y., Miyamoto, K., Haga, H., et al. (1999) Identification of an amino acid transporter associated with the cystinuria-related type II membrane glycoprotein. J. Biol. Chem. 274, 28845–28848.
19. Verrey, F., Closs, E. I., Wagner, C. A., Palacin, M., Endou, H., et al. (2004) CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch. 447, 532–542.
20. Aoyama, K., Suh, S. W., Hamby, A. M., Liu, J., Chan, W. Y., et al. (2006) Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat. Neurosci. 9, 119–126.
21. Zerangue, N., and Kavanaugh, M. P. (1996) Interaction of L-cysteine with a human excitatory amino acid transporter. J. Physiol. 493, 419–423.
22. Sato, H., Tamba, M., Okuno, S., Sato, K., Keino-Masu, K., et al. (2002) Distribution of cystine/glutamate exchange transporter, system x(c)-, in the mouse brain. J. Neurosci. 22, 8028–8033.
23. Murphy, T. H., Miyamoto, M., Sastre, A., Schnaar, R. L., and Coyle, J. T. (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2, 1547–1558.
24. Murphy, T. H., Schnaar, R. L., and Coyle, J. T. (1990) Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J. 4, 1624–1633.
25. Had-Aissouni, L. (2012) Toward a new role for plasma membrane sodium-dependent glutamate transporters of astrocytes: maintenance of antioxidant defenses beyond extracellular glutamate clearance. Amino Acids 42, 181–197.
26. Schubert, D., Kimura, H., and Maher, P. (1992) Growth factors and vitamin E modify neuronal glutamate toxicity. Proc. Natl. Acad. Sci. U. S. A. 89, 8264–8267.
27. Li, Y., Maher, P., and Schubert, D. (1997) A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19, 453–463.
28. Tan, S., Schubert, D., and Maher, P. (2001) Oxytosis: a novel form of programmed cell death. Curr. Top. Med. Chem. 1, 497–506.
29. Seiler, A., Schneider, M., Forster, H., Roth, S., Wirth, E. K., et al. (2008) Glutathione Peroxidase 4 Senses and Translates Oxidative Stress into 12/15-Lipoxygenase Dependent- and AIF-Mediated Cell Death. Cell Metab. 8, 237–248.
30. Dolma, S., Lessnick, S. L., Hahn, W. C., and Stockwell, B. R. (2003) Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3, 285–296.
31. Yang, W. S., and Stockwell, B. R. (2008) Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 15, 234–245.
32. Shimada, K., Hayano, M., Pagano, N. C., and Stockwell, B. R. (2016) Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity. Cell Chem. Biol. 23, 225–235.
33. Kim, S. E., Zhang, L., Ma, K., Riegman, M., Chen, F., et al. (2016) Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth. Nat. Nanotechnol. 11, 977–985.
34. Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., et al. (2017) ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13, 91–98.
35. Magtanong, L., Ko, P. J., and Dixon, S. J. (2016) Emerging roles for lipids in non-apoptotic cell death. Cell Death Differ. 23, 1099–1109.
36. Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A. J., Yang, W. S., et al. (2007) RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447, 864–868.
37. Yang, W. S., Kim, K. J., Gaschler, M. M., Patel, M., Shchepinov, M. S., et al. (2016) Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc. Natl. Acad. Sci. U. S. A. 113, E4966–E4975.
38. Skouta, R., Dixon, S. J., Wang, J., Dunn, D. E., Orman, M., et al. (2014) Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J. Am. Chem. Soc. 136, 4551–4556.
39. Zilka, O., Shah, R., Li, B., Angeli Friedmann, P., Griesser, M., et al. On the Mechanism of Cytoprotection by Ferrostatin-1 & Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death, submitted.
40. Friedmann Angeli, J. P., Shah, R., Pratt, D. A. & Conrad, M. Ferroptosis inhibition, mechanisms and applications, Trends Pharmacol. Sci. Accepted.
41. Dixon, S. J., Winter, G. E., Musavi, L. S., Lee, E. D., Snijder, B., et al. (2015) Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death. ACS Chem. Biol. 10, 1604–1609.
42. Kagan, V. E., Mao, G., Qu, F., Angeli, J. P., Doll, S., et al. (2017) Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat. Chem. Biol. 13, 81–90.
43. Gao, M., Monian, P., Pan, Q., Zhang, W., Xiang, J., et al. (2016) Ferroptosis is an autophagic cell death process. Cell Res. 26, 1021–1032.
44. Gao, M., Monian, P., Quadri, N., Ramasamy, R., and Jiang, X. (2015) Glutaminolysis and Transferrin Regulate Ferroptosis. Mol. Cell 59, 298–308.
45. Harrison, P. M., and Arosio, P. (1996) The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1275, 161–203.
46. Hou, W., Xie, Y., Song, X., Sun, X., Lotze, M. T., et al. (2016) Autophagy promotes ferroptosis by degradation of ferritin. Autophagy 12, 1425–1428.
47. Torii, S., Shintoku, R., Kubota, C., Yaegashi, M., Torii, R., et al. (2016) An essential role for functional lysosomes in ferroptosis of cancer cells. Biochem. J. 473, 769–777.
48. Gout, P. W., Buckley, A. R., Simms, C. R., and Bruchovsky, N. (2001) Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug. Leukemia 15, 1633–1640.
49. Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., et al. (2014) Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife 3, e02523.
50. Bannai, S., and Kitamura, E. (1980) Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. J. Biol. Chem. 255, 2372–2376.
51. Kobayashi, S., Sato, M., Kasakoshi, T., Tsutsui, T., Sugimoto, M., et al. (2015) Cystathionine is a novel substrate of cystine/glutamate transporter: implications for immune function. J. Biol. Chem. 290, 8778–8788.
52. Hayano, M., Yang, W. S., Corn, C. K., Pagano, N. C., and Stockwell, B. R. (2016) Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation. Cell Death Differ 23, 270–278.
53. Jiang, L., Kon, N., Li, T., Wang, S. J., Su, T., et al. (2015) Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520, 57–62.
54. Mandal, P. K., Seiler, A., Perisic, T., Kolle, P., Banjac Canak, A., et al. (2010) System x(c)- and thioredoxin reductase 1 cooperatively rescue glutathione deficiency. J. Biol. Chem. 285, 22244–22253.
55. Griffith, O. W. (1999) Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic. Biol. Med. 27, 922–935.
56. Dickinson, D. A., and Forman, H. J. (2002) Cellular glutathione and thiols metabolism. Biochem. Pharmacol. 64, 1019–1026.
57. Jez, J. M., and Cahoon, R. E. (2004) Kinetic mechanism of glutathione synthetase from Arabidopsis thaliana. J. Biol. Chem. 279, 42726–42731.
58. Ursini, F., Maiorino, M., Valente, M., Ferri, L., and Gregolin, C. (1982) Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochim. Biophys. Acta 710, 197–211.
59. Woo, J. H., Shimoni, Y., Yang, W. S., Subramaniam, P., Iyer, A., et al. (2015) Elucidating Compound Mechanism of Action by Network Perturbation Analysis. Cell 162, 441–451.
60. Pratt, D. A., Tallman, K. A., and Porter, N. A. (2011) Free radical oxidation of polyunsaturated lipids: new mechanistic insights and the development of peroxyl radical clocks. Acc. Chem. Res. 44, 458–467.
61. Shimada, K., Skouta, R., Kaplan, A., Yang, W. S., Hayano, M., et al. (2016) Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat. Chem. Biol. 12, 497–503.
62. Yant, L. J., Ran, Q., Rao, L., Van Remmen, H., Shibatani, T., et al. (2003) The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic. Biol. Med. 34, 496–502.
63. Friedmann Angeli, J. P., Proneth, B. & Conrad, M. (2016) In Selenium: Its Molecular Biology and Role in Human Health, 4th edn. (Hatfield, D. L., Schweizer, U., Tsuji, P. A. & Gladyshev, V. N., eds.). pp. 511–521, Springer International Publishing, New York.
64. Wirth, E. K., Conrad, M., Winterer, J., Wozny, C., Carlson, B. A., et al. (2010) Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration. FASEB J. 24, 844–852.
65. Wirth, E. K., Bharathi, B. S., Hatfield, D., Conrad, M., Brielmeier, M., et al. (2014) Cerebellar hypoplasia in mice lacking selenoprotein biosynthesis in neurons. Biol. Trace Elem. Res. 158, 203–210.
66. Chen, L., Hambright, W. S., Na, R., and Ran, Q. (2015) Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis. J. Biol. Chem. 290, 28097–28106.
67. Ueta, T., Inoue, T., Furukawa, T., Tamaki, Y., Nakagawa, Y., et al. (2012) Glutathione peroxidase 4 is required for maturation of photoreceptor cells. J. Biol. Chem. 287, 7675–7682.
68. Matsushita, M., Freigang, S., Schneider, C., Conrad, M., Bornkamm, G. W., et al. (2015) T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J. Exp. Med. 212, 555–568.
69. Wortmann, M., Schneider, M., Pircher, J., Hellfritsch, J., Aichler, M., et al. (2013) Combined deficiency in glutathione peroxidase 4 and vitamin E causes multiorgan thrombus formation and early death in mice. Circ. Res. 113, 408–417.
70. Carlso, B. A., Tob, R., Yefremov, E., Tsuj, P. A., Hoffman, V. J., Schweize, U., Gladyshe, V. N., Hatfiel, D. L., Conra, M. (2016) Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration. Redox Biol. 9, 22–31.
71. Gutteridge, J. M., and Halliwell, B. (1989) Iron toxicity and oxygen radicals. Baillieres Clin. Haematol. 2, 195–256.
72. Halliwell, B., and Cross, C. E. (1994) Oxygen-derived species: their relation to human disease and environmental stress. Environ. Health Perspect. 102 Suppl 10, 5–12.
73. Grivennikova, V. G., and Vinogradov, A. D. (2006) Generation of superoxide by the mitochondrial Complex I. Biochim. Biophys. Acta 1757, 553–561.
74. Kakhlon, O., and Cabantchik, Z. I. (2002) The labile iron pool: characterization, measurement, and participation in cellular processes(1). Free Radic. Biol. Med. 33, 1037–1046.
75. Bogdan, A. R., Miyazawa, M., Hashimoto, K., and Tsuji, Y. (2016) Regulators of Iron Homeostasis: new Players in Metabolism, Cell Death, and Disease. Trends Biochem. Sci. 41, 274–286.
76. Mancias, J. D., Wang, X., Gygi, S. P., Harper, J. W., and Kimmelman, A. C. (2014) Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509, 105–109.
77. Dixon, S. J., and Stockwell, B. R. (2014) The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10, 9–17.
78. Yamanaka, K., Saito, Y., Sakiyama, J., Ohuchi, Y., Oseto, F., et al. (2012) A novel fluorescent probe with high sensitivity and selective detection of lipid hydroperoxides in cells. RSC Adv. 2, 7894–7900.
79. Drummen, G. P., van Liebergen, L. C., Op den Kamp, J. A., and Post, J. A. (2002) C11-BODIPY(581/591), an oxidation-sensitive fluorescent lipid peroxidation probe: (micro)spectroscopic characterization and validation of methodology. Free Radic. Biol. Med. 33, 473–490.
80. Bolland, J. L. (1949) Kinetics of olefin oxidation. Q. Rev. Chem. Soc. 1–21.
81. Bateman, L. Q. (1954) Olefin oxidation. Q. Rev. Chem. Soc. 8, 147–167.
82. Schneider, C., Porter, N. A., and Brash, A. R. (2008) Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation. J. Biol. Chem. 283, 15539–15543.
83. Porter, N. A. (1986) Mechanisms for the Autoxidation of Polyunsaturated Lipids. Acc. Chem. Res. 19, 262–268.
84. Davies, S. S., and Guo, L. (2014) Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids. Chem. Phys. Lipids 181, 1–33.
85. Maillard, B., Ingold, K. U., and Scaiano, J. C. (1983) Rate constants for the reactions of free radicals with oxygen in solution. J. Am. Chem. Soc. 105, 5095–5099.
86. Buettner, G. R. (1993) The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch. Biochem. Biophys. 300, 535–543.
87. Howard, J. (1972) Absolute rate constants for reactions of oxyl radicals. Adv. Free Radic. Chem. 4, 49–173.
88. Morita, M., and Fujimaki, M. (1973) Non-hydroperoxy-type peroxides as autocatalysts of lipid autoxidation. Agric. Biol. Chem. 37, 1213–1214.
89. Spickett, C. M. (2013) The lipid peroxidation product 4-hydroxy-2-nonenal: advances in chemistry and analysis. Redox Biol. 1, 145–152.
90. Morita, M., and Tokita, M. (2006) The real radical generator other than main-product hydroperoxide in lipid autoxidation. Lipids 41, 91–95.
91. Gueraud, F., Atalay, M., Bresgen, N., Cipak, A., Eckl, P. M., et al. (2010) Chemistry and biochemistry of lipid peroxidation products. Free Radic. Res. 44, 1098–1124.
92. Kuhn, H., Banthiya, S., and van Leyen, K. (2015) Mammalian lipoxygenases and their biological relevance. Biochim. Biophys. Acta 1851, 308–330.
93. Kuhn, H., Belkner, J., Wiesner, R., and Brash, A. R. (1990) Oxygenation of biological membranes by the pure reticulocyte lipoxygenase. J. Biol. Chem. 265, 18351–18361.
94. Brash, A. R., and Ingram, C. D. (1986) Lipoxygenase metabolism of endogenous and exogenous arachidonate in leukocytes: GC-MS analyses of incubations in H2(18)O buffers. Prostaglandins Leukot. Med. 23, 149–154.
95. Maskrey, B. H., Bermudez-Fajardo, A., Morgan, A. H., Stewart-Jones, E., Dioszeghy, V., et al. (2007) Activated platelets and monocytes generate four hydroxyphosphatidylethanolamines via lipoxygenase. J. Biol. Chem. 282, 20151–20163.
96. Morgan, L. T., Thomas, C. P., Kuhn, H., and O'Donnell, V. B. (2010) Thrombin-activated human platelets acutely generate oxidized docosahexaenoic-acid-containing phospholipids via 12-lipoxygenase. Biochem. J. 431, 141–148.
97. Clark, S. R., Guy, C. J., Scurr, M. J., Taylor, P. R., Kift-Morgan, A. P., et al. (2011) Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infection. Blood 117, 2033–2043.
98. Brutsch, S. H., Wang, C. C., Li, L., Stender, H., Neziroglu, N., et al. (2015) Expression of inactive glutathione peroxidase 4 leads to embryonic lethality, and inactivation of the Alox15 gene does not rescue such knock-in mice. Antioxid. Redox Signal 22, 281–293.
99. Remita, S. (2001) [Radiation induced lipid peroxidation: factors which determine the oxidizability of lipids]. Can. J. Physiol. Pharmacol. 79, 144–153.
100. Lukacs, Z., Gieseking, J., Finckh, B., and Kohlschutter, A. (2003) Membrane oxidation assay–a novel lipoxygenase-based evaluation of membrane oxidizability. Free Radic. Res. 37, 413–417.
101. Vance, J. E. (2008) Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids. J. Lipid Res. 49, 1377–1387.
102. Furt, F., and Moreau, P. (2009) Importance of lipid metabolism for intracellular and mitochondrial membrane fusion/fission processes. Int. J. Biochem. Cell Biol. 41, 1828–1836.
103. Birner, R., Burgermeister, M., Schneiter, R., and Daum, G. (2001) Roles of phosphatidylethanolamine and of its several biosynthetic pathways in Saccharomyces cerevisiae. Mol. Biol. Cell 12, 997–1007.
104. Schroeder, F. (1980) Regulation of aminophospholipid asymmetry in murine fibroblast plasma membranes by choline and ethanolamine analogues. Biochim. Biophys. Acta 599, 254–270.
105. Tang, X., Halleck, M. S., Schlegel, R. A., and Williamson, P. (1996) A subfamily of P-type ATPases with aminophospholipid transporting activity. Science 272, 1495–1497.
106. Kainu, V., Hermansson, M., Hanninen, S., Hokynar, K., and Somerharju, P. (2013) Import of phosphatidylserine to and export of phosphatidylethanolamine molecular species from mitochondria. Biochim. Biophys. Acta 1831, 429–437.
107. Wong-Ekkabut, J., Xu, Z., Triampo, W., Tang, I. M., Tieleman, D. P., et al. (2007) Effect of lipid peroxidation on the properties of lipid bilayers: a molecular dynamics study. Biophys. J. 93, 4225–4236.
108. Jacobs, A. T., and Marnett, L. J. (2010) Systems analysis of protein modification and cellular responses induced by electrophile stress. Acc. Chem. Res. 43, 673–683.
109. Poli, G., Schaur, R. J., Siems, W. G., and Leonarduzzi, G. (2008) 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med. Res. Rev. 28, 569–631.
110. Hammond, V. J., Morgan, A. H., Lauder, S., Thomas, C. P., Brown, S., et al. (2012) Novel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-gamma. J. Biol. Chem. 287, 41651–41666.
111. Higdon, A., Diers, A. R., Oh, J. Y., Landar, A., and Darley-Usmar, V. M. (2012) Cell signalling by reactive lipid species: new concepts and molecular mechanisms. Biochem. J. 442, 453–464.
112. Slatter, D. A., Aldrovandi, M., O'Connor, A., Allen, S. M., Brasher, C. J., et al. (2016) Mapping the Human Platelet Lipidome Reveals Cytosolic Phospholipase A2 as a Regulator of Mitochondrial Bioenergetics during Activation. Cell Metab. 23, 930–944.
113. Choudhary, S., Xiao, T., Srivastava, S., Zhang, W., Chan, L. L., et al. (2005) Toxicity and detoxification of lipid-derived aldehydes in cultured retinal pigmented epithelial cells. Toxicol. Appl. Pharmacol. 204, 122–134.
114. Lieberman, M. W., Wiseman, A. L., Shi, Z. Z., Carter, B. Z., Barrios, R., et al. (1996) Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 93, 7923–7926.
115. Esterbauer, H., Benedetti, A., Lang, J., Fulceri, R., Fauler, G., et al. (1986) Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation. Biochim. Biophys. Acta 876, 154–166.
116. Poli, G., and Schaur, R. J. (2000) 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50, 315–321.
117. Catala, A. (2009) Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem. Phys. Lipids 157, 1–11.
118. Esterbauer, H., Zollner, H., and Schaur, R. J. (1990) Aldehydes formed by lipid peroxidation: mechanisms of formation, occurrence, and determination. Membr. Lipid Oxidation 1, 239–268.
119. Fang, X., Fu, Y., Long, M. J., Haegele, J. A., Ge, E. J., et al. (2013) Temporally controlled targeting of 4-hydroxynonenal to specific proteins in living cells. J. Am. Chem. Soc. 135, 14496–14499.